| Product Name | Therapeutic Class | Regulatory | CAS | Remarks |
|---|---|---|---|---|
| APIXABAN | Anticoagulant | Canada, EU DMF | 503612-47-3 | |
| ARMODAFINIL | Wakefulness‐promoting agent | US DMF in CTD Format | 112111-43-0 | |
| BENAZEPRIL HYDROCHILORIDE | Antihypertensive | JP, US DMF in CTD Format | 86541-74-4 | |
| BOSENTAN MONOHYDRATE | Antihypertensive | EU DMF, US DMF in CTD Format | 157212-55-0 | |
| CINACALCET HYDROCHLORIDE | Antihyperparathyroidism | EU DMF | 364782-34-3 | |
| CYPROHEPTADINE OROTATE | Antihistaminic | EU DMF | 41354-29-4 | Sent only MMA |
| DEXTROPROPOXYPHENE HCI | ||||
| FOSINOPRIL SODIUM | EU DMF, US DMF in CTD format, TAIWAN | |||
| PALIPERIDONE | Schizophrenia | US DMF in CTD format, TAIWAN | 144598‐75‐4 | |
| PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE | Antiparkinsonian | EU DMF, US in CTD format type II, TAIWAN | 191217‐81‐9 | COS / CEP |
| PRAMIPEXOLE FREE BASE | US DMF | |||
| RABEPRAZOLE SODIUM MONOHYDRATE | Antiulcerative | EU DMF | 891191‐56‐3 | |
| RABEPRAZOLE SODIUM from HYDROXY INTERMEDIATE | EU DMF | |||
| RASAGILINE MESYLATE | Antiparkinsonian | US DMF in CTD format | 161735‐79‐1 | |
| RASAGILINE TARTRATE | Antiparkinsonian | EU DMF in CTD format | 136236‐52‐7 | |
| TELMISARTAN | Antihypertensive | EU DMF, US in CTD format type II | 144701‐48‐4 | |
| TERBINAFINE HYDROCHLORIDE | Antifungal | EU DMF, US in CTD format type II | 78628‐80‐5 | COS / CEP |
| TOLTERODINE TARTRATE | Treatment of urinary incontinence | EU DMF, US in CTD format type II, TAIWAN | 124937‐52‐6 | |
| ZIPRASIDONE HYDROCHLORIDE ANHYDROUS | Antipsychotic | EU DMF | 122883‐93‐6 | |
| ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE | Antipsychotic | EU DMF, US in CTD format type II | 138982‐67‐9 | COS / CEP |
